Advanced search
2 files | 405.55 KB

Predicting the outcome of ankylosing spondylitis therapy

Author
Organization
Keywords
Immunology, Biochemistry, Genetics and Molecular Biology(all), Immunology and Allergy, Rheumatology, DISEASE-ACTIVITY INDEX, NECROSIS FACTOR TREATMENT, PLACEBO-CONTROLLED TRIAL, MAJOR CLINICAL-RESPONSE, ACTIVITY SCORE ASDAS, ANTI-TNF THERAPY, INFLIXIMAB, SAFETY, EPIDEMIOLOGY, IMPROVEMENT

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 360.13 KB
  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 45.41 KB

Citation

Please use this url to cite or link to this publication:

Chicago
Vastesaeger, Nathan, Désirée van der Heijde, Robert D Inman, Yanxin Wang, Atul Deodhar, Benjamin Hsu, Mahboob U Rahman, et al. 2011. “Predicting the Outcome of Ankylosing Spondylitis Therapy.” Annals of the Rheumatic Diseases 70 (6): 973–981.
APA
Vastesaeger, N., van der Heijde, D., Inman, R. D., Wang, Y., Deodhar, A., Hsu, B., Rahman, M. U., et al. (2011). Predicting the outcome of ankylosing spondylitis therapy. ANNALS OF THE RHEUMATIC DISEASES, 70(6), 973–981.
Vancouver
1.
Vastesaeger N, van der Heijde D, Inman RD, Wang Y, Deodhar A, Hsu B, et al. Predicting the outcome of ankylosing spondylitis therapy. ANNALS OF THE RHEUMATIC DISEASES. 2011;70(6):973–81.
MLA
Vastesaeger, Nathan, Désirée van der Heijde, Robert D Inman, et al. “Predicting the Outcome of Ankylosing Spondylitis Therapy.” ANNALS OF THE RHEUMATIC DISEASES 70.6 (2011): 973–981. Print.
@article{8500055,
  author       = {Vastesaeger, Nathan and van der Heijde, D{\'e}sir{\'e}e and Inman, Robert D and Wang, Yanxin and Deodhar, Atul and Hsu, Benjamin and Rahman, Mahboob U and Dijkmans, Ben and Geusens, Piet and Vander Cruyssen, Bert and Collantes, Eduardo and Sieper, Joachim and Braun, J{\"u}rgen},
  issn         = {0003-4967},
  journal      = {ANNALS OF THE RHEUMATIC DISEASES},
  keyword      = {Immunology,Biochemistry,Genetics and Molecular Biology(all),Immunology and Allergy,Rheumatology,DISEASE-ACTIVITY INDEX,NECROSIS FACTOR TREATMENT,PLACEBO-CONTROLLED TRIAL,MAJOR CLINICAL-RESPONSE,ACTIVITY SCORE ASDAS,ANTI-TNF THERAPY,INFLIXIMAB,SAFETY,EPIDEMIOLOGY,IMPROVEMENT},
  language     = {eng},
  number       = {6},
  pages        = {973--981},
  title        = {Predicting the outcome of ankylosing spondylitis therapy},
  url          = {http://dx.doi.org/10.1136/ard.2010.147744},
  volume       = {70},
  year         = {2011},
}

Altmetric
View in Altmetric
Web of Science
Times cited: